Horizon Discovery Group Plc (HZD):企業の財務・戦略的SWOT分析

◆英語タイトル:Horizon Discovery Group Plc (HZD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH132463FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers services such as CRISPR screening, in vivo assay services, combination screening and cell-based assays, among others. Horizon Discovery offers its products and services to genomic research organizations, biotechnology and diagnostic companies, pharmaceutical and academic research centers for the formulation of customized medicines. The company has operations in the UK and the US. Horizon Discovery is headquartered in Cambridge, the UK.

Horizon Discovery Group Plc Key Recent Developments

Mar 29,2021: Horizon Discovery extends gene modulation portfolio with industry first synthetic single guide RNA and patent pending dCas9 repressor for CRISPR interference
Feb 04,2021: PerkinElmer’s Horizon Discovery CHOSOURCE cell line supports Trinomab Biotech’s development of the world-first, Tetanus Toxin mAb drug for clinical trials
Aug 17,2020: Horizon Discovery Group: Results for the six months ended 30 June 2020
Aug 04,2020: Horizon Discovery introduces single cell RNAseq-linked CRISPR screening service

This comprehensive SWOT profile of Horizon Discovery Group Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Horizon Discovery Group Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Horizon Discovery Group Plc – Key Information
Horizon Discovery Group Plc – Overview
Horizon Discovery Group Plc – Key Employees
Horizon Discovery Group Plc – Key Employee Biographies
Horizon Discovery Group Plc – Key Operational Heads
Horizon Discovery Group Plc – Major Products and Services
Horizon Discovery Group Plc – History
Horizon Discovery Group Plc – Company Statement
Horizon Discovery Group Plc – Locations And Subsidiaries
Horizon Discovery Group Plc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Horizon Discovery Group Plc – Business Description
Horizon Discovery Group Plc – Corporate Strategy
Horizon Discovery Group Plc – SWOT Analysis
SWOT Analysis – Overview
Horizon Discovery Group Plc – Strengths
Horizon Discovery Group Plc – Weaknesses
Horizon Discovery Group Plc – Opportunities
Horizon Discovery Group Plc – Threats
Horizon Discovery Group Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Horizon Discovery Group Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Horizon Discovery Group Plc, Key Information
Horizon Discovery Group Plc, Key Ratios
Horizon Discovery Group Plc, Share Data
Horizon Discovery Group Plc, Major Products and Services
Horizon Discovery Group Plc, History
Horizon Discovery Group Plc, Key Employees
Horizon Discovery Group Plc, Key Employee Biographies
Horizon Discovery Group Plc, Key Operational Heads
Horizon Discovery Group Plc, Other Locations
Horizon Discovery Group Plc, Subsidiaries
Horizon Discovery Group Plc, Key Competitors
Horizon Discovery Group Plc, SWOT Analysis
Horizon Discovery Group Plc, Ratios based on current share price
Horizon Discovery Group Plc, Annual Ratios
Horizon Discovery Group Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Horizon Discovery Group Plc (HZD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rockhopper Exploration PLC (RKH):企業の財務・戦略的SWOT分析
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • State Oil Company of the Azerbaijan Republic:石油・ガス:M&Aディール及び事業提携情報
    Summary State Oil Company of the Azerbaijan Republic (SOCAR) is an oil and gas exploration company. The company explores oil and gas fields; and produces, processes and transports oil, gas and gas condensate. It markets petroleum and petrochemical products in domestic and international markets and s …
  • SIFI SpA-製薬・医療分野:企業M&A・提携分析
    Summary SIFI SpA (SIFI) is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of the most common ocular pathologies. SIFI develops its produc …
  • Asseco Poland SA (ACP):企業の財務・戦略的SWOT分析
    Summary Asseco Poland SA (Asseco) is a technology company that offers information processing solutions. The company offers banking, insurance companies, public institutions, healthcare, telecommunication, utilities, ERP solutions, IT infrastructure and others. Its IT infrastructure solutions include …
  • Caterpillar Inc (CAT)-エネルギー分野:企業M&A・提携分析
    Summary Caterpillar Inc. (Caterpillar) is a manufacturer of construction, transportation and energy equipment. It designs, manufactures, markets and sells construction and mining equipment, industrial gas turbines, forestry machinery, diesel and natural gas engines, and diesel-electric locomotives. …
  • United Biscuits (UK) Ltd:企業の戦略・SWOT・財務分析
    United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Air Methods Corp:企業の戦略的SWOT分析
    Air Methods Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • PacWest Bancorp:企業の戦略・SWOT・財務情報
    PacWest Bancorp - Strategy, SWOT and Corporate Finance Report Summary PacWest Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Trinity Health:企業の戦略的SWOT分析
    Trinity Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • TES Aviation Group:企業の戦略・SWOT・財務情報
    TES Aviation Group - Strategy, SWOT and Corporate Finance Report Summary TES Aviation Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Midatech Pharma Plc (MTPH):医療機器:M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Xilinx, Inc.:企業の戦略・SWOT・財務分析
    Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report Summary Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析
    Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務情報
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • ALLETE Inc (ALE)-エネルギー分野:企業M&A・提携分析
    Summary ALLETE, Inc. (ALLETE) is an energy company that operates varied businesses in the energy sector. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. It provides energy in the upper Midwest in the US; and inves …
  • CareDx Inc (CDNA):製薬・医療:M&Aディール及び事業提携情報
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • University of York-製薬・医療分野:企業M&A・提携分析
    Summary University of York (York) is an educational and research university that offers academic research and teaching services. The university offers commercial facilities and services, funding collaborative research, knowledge transfer partnerships, professional development and training, consultan …
  • bioMerieux Inc-医療機器分野:企業M&A・提携分析
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆